Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Tisagenlecleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Tisagenlecleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Axicabtagene Ciloleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Axicabtagene Ciloleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Brexucabtagene Autoleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Brexucabtagene Autoleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Lisocabtagene Maraleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Lisocabtagene Maraleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Idecabtagene Vicleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Idecabtagene Vicleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Ciltacabtagene Autoleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Ciltacabtagene Autoleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Obecabtagene Autoleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Obecabtagene Autoleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Anitocabtagene Autoleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Anitocabtagene Autoleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
Equecabtagene Autoleucel |
Chimeric Antigen Receptor T-Cell Therapy | Hematologic (Leukemia/Lymphoma/Myeloma) | ||
|
Molecule
Equecabtagene Autoleucel
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
||||
TisagenlecleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Axicabtagene CiloleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Brexucabtagene AutoleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Lisocabtagene MaraleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Idecabtagene VicleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Ciltacabtagene AutoleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Obecabtagene AutoleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Anitocabtagene AutoleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|
Equecabtagene AutoleucelCellular Therapy (CAR-T) |
|
|
Therapeutic Category
Cellular Therapy (CAR-T)
Oncology Type
Hematologic (Leukemia/Lymphoma/Myeloma)
Drug Class / Mechanism
Chimeric Antigen Receptor T-Cell Therapy |
|

